Skip to main content
Fred Ghali, MD, Dermatology, Grapevine, TX

Fred Elias Ghali MD

Pediatric Dermatology


Physician

Join to View Full Profile
  • 1325 W. Northwest HwyGrapevine, TX 76051

  • Phone+1 817-421-3376

  • Fax+1 817-416-4269

Dr. Ghali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Dermatology, 1996 - 1999
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pediatrics, 1993 - 1996
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1993

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1995 - 2026
  • NC State Medical License
    NC State Medical License 1996 - 2000
  • IL State Medical License
    IL State Medical License 1998 - 1998
  • Dermatology
    American Board of Dermatology Dermatology
  • Pediatric Dermatology
    American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Top MD Consumers Checkbook
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Platinum Dermatology Adds North Texas Pediatrics Practice to Network
    Platinum Dermatology Adds North Texas Pediatrics Practice to NetworkAugust 10th, 2017
  • Pediatric Dermatology of North Texas Joins Platinum Dermatology Partners
    Pediatric Dermatology of North Texas Joins Platinum Dermatology PartnersAugust 10th, 2017
  • Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis
    Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic DermatitisOctober 31st, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: